- Trials with a EudraCT protocol (5)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
5 result(s) found for: Subcostal plane.
Displaying page 1 of 1.
EudraCT Number: 2016-004377-41 | Sponsor Protocol Number: TFP_1-1 | Start Date*: 2016-12-19 | |||||||||||
Sponsor Name:Dep. Anaesthesia and Intensive Care, Aarhus University Hospital | |||||||||||||
Full Title: Regional anaesthesia of the cutaneus nerves of the hip - A randomized controlled trial of the transversalis fascia plane block | |||||||||||||
Medical condition: Postoperative pain after hip surgery | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-000732-22 | Sponsor Protocol Number: OSTAP | Start Date*: 2020-05-18 |
Sponsor Name:Pablo Rama Maceiras | ||
Full Title: Effectiveness comparative study of oblique subcostal transversus abdominis plane block (OSTAP block) versus laparoscopic ports infiltration in patients undergoing elective cholecystectomy. | ||
Medical condition: Elective cholecystectomy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-001657-28 | Sponsor Protocol Number: CTHC002 | Start Date*: 2014-01-23 | |||||||||||
Sponsor Name:University Medical Center of the Johannes Gutenberg University Mainz | |||||||||||||
Full Title: Home Treatment of Patients with Low-Risk Pulmonary Embolism with the Oral Factor Xa Inhibitor Rivaroxaban: Prospective Management Trial (HoT-PE) | |||||||||||||
Medical condition: Acute low-risk pulmonary embolism (PE) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) PT (Completed) FI (Completed) ES (Completed) NL (Completed) GR (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-000816-96 | Sponsor Protocol Number: P160924 | Start Date*: 2020-04-27 |
Sponsor Name:AP-HP/ DRCI | ||
Full Title: A reduced dose of thrombolytic treatment for patients with intermediate high-risk acute pulmonary embolism | ||
Medical condition: Intermediate high-risk acute pulmonary embolism | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Trial now transitioned) AT (Trial now transitioned) DE (Trial now transitioned) NL (Trial now transitioned) ES (Ongoing) IT (Trial now transitioned) SI (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2017-000552-25 | Sponsor Protocol Number: DS9231-A-U201 | Start Date*: 2017-08-07 | ||||||||||||||||
Sponsor Name:Daiichi Sankyo Inc. | ||||||||||||||||||
Full Title: Evaluation of Safety and Thrombolytic Effect of Ascending Doses of DS-9231 (TS23) in Subjects with Intermediate-Risk (sub-massive) Acute Pulmonary Embolism (PE) | ||||||||||||||||||
Medical condition: DS9231, also known as TS23, is an inhibitor of alpha2-antiplasmin, incrasing plasmin acitivy and enhances fibrinolysis (thrombolysis) and intended to be used for the treatment of patients with Inte... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: HU (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
